<?xml version="1.0" encoding="UTF-8"?>
<ref id="B211">
 <label>211.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cugno</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Meroni</surname>
    <given-names>PL</given-names>
   </name>
   <name>
    <surname>Gualtierotti</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Griffini</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Grovetti</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Torri</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Complement activation in patients with COVID-19: A novel therapeutic target</article-title>. 
  <source>J Allergy Clin Immunol</source>. (
  <year>2020</year>). [Epub ahead of print]. 
  <pub-id pub-id-type="doi">10.1016/j.jaci.2020.05.006</pub-id>.
  <?supplied-pmid 32417135?>
  <pub-id pub-id-type="pmid">32417135</pub-id>
 </mixed-citation>
</ref>
